Martin Glennie

Last updated

Martin J. Glennie is emeritus professor of immunochemistry (antibodies) at the University of Southampton, England. [1]

Contents

Career

Glennie earned his BSc and PhD at the University of Southampton, and is the current Head of the Cancer Sciences Unit there. [1] Glennie is on the editorial board of the scientific journal mAbs (monoclonal antibodies) published by the Taylor & Francis Group. [2]

Public media interest

The clinical trial of an anti-CD40 monoclonal antibody chiLOB7/4 developed in Glennie's laboratory was reported by The Daily Telegraph in August 2013. [3] Glennie stressed that “Ipilimumab works by taking the brakes off part of the immune system called T cells, while our compound revs up the T cells – it is like giving them a caffeine hit.". [3]

Personal life

Glennie is a keen angler, winning second prize (Lupa cup) in the Baltimore Deep Sea angling Festival 2014, South West Ireland. [4]

References

  1. 1 2 "University of Southampton Faculty of Medicine Staff page". University of Southampton. Retrieved 11 December 2014.
  2. ↑ "mAbs editorial board" . Retrieved 11 December 2014.
  3. 1 2 Gray, Richard (2013-08-11). "New Immunity Boosting Drug Helps Body Kill Cancer". Archived from the original on 2013-08-14. Retrieved 11 December 2014.
  4. ↑ "Baltimore Deep Sea Angling Festival 2014" . Retrieved 11 December 2014.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.